Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

A point-of-care paper-based fingerstick transaminase test: toward low-cost "lab-on-a-chip" technology for the developing world.

Pollock NR, Colby D, Rolland JP.

Clin Gastroenterol Hepatol. 2013 May;11(5):478-82. doi: 10.1016/j.cgh.2013.02.022. Epub 2013 Mar 4.

2.

Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test.

Pollock NR, McGray S, Colby DJ, Noubary F, Nguyen H, Nguyen TA, Khormaee S, Jain S, Hawkins K, Kumar S, Rolland JP, Beattie PD, Chau NV, Quang VM, Barfield C, Tietje K, Steele M, Weigl BH.

PLoS One. 2013 Sep 30;8(9):e75616. doi: 10.1371/journal.pone.0075616. eCollection 2013.

3.

A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing.

Pollock NR, Rolland JP, Kumar S, Beattie PD, Jain S, Noubary F, Wong VL, Pohlmann RA, Ryan US, Whitesides GM.

Sci Transl Med. 2012 Sep 19;4(152):152ra129.

4.

Performance of an Optimized Paper-Based Test for Rapid Visual Measurement of Alanine Aminotransferase (ALT) in Fingerstick and Venipuncture Samples.

Jain S, Rajasingham R, Noubary F, Coonahan E, Schoeplein R, Baden R, Curry M, Afdhal N, Kumar S, Pollock NR.

PLoS One. 2015 May 28;10(5):e0128118. doi: 10.1371/journal.pone.0128118. eCollection 2015.

5.

Validity of a point of care device (Cholestech LDX) to monitor liver enzyme activity (aminotransferase measures) during a clinical trial.

Green JL, Reifler LM, Heard KJ.

Contemp Clin Trials. 2010 Jul;31(4):279-82. doi: 10.1016/j.cct.2010.04.001. Epub 2010 Apr 27.

6.

A low cost point-of-care viscous sample preparation device for molecular diagnosis in the developing world; an example of microfluidic origami.

Govindarajan AV, Ramachandran S, Vigil GD, Yager P, Böhringer KF.

Lab Chip. 2012 Jan 7;12(1):174-81. doi: 10.1039/c1lc20622b. Epub 2011 Nov 8.

PMID:
22068336
7.

Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.

Sonsuz A, Basaranoglu M, Ozbay G.

Am J Gastroenterol. 2000 May;95(5):1370-1. No abstract available.

PMID:
10811364
8.

Two dry-reagent systems evaluated for determinations of enzyme activities.

Hafkenscheid JC, van der Ven-Jongekrijg J.

Clin Chem. 1988 Jan;34(1):155-7.

9.

[Enzyme-diagnostic mass screening of hepatitis using a new test procedure (KAPA)].

Thielmann K, Horn A, Klemmt D, Bublitz R, Horn B, Ballaschke R, Buhler H.

Dtsch Gesundheitsw. 1972 Aug 17;27(33):1575-84. German. No abstract available.

PMID:
5079017
10.

Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.

Raamanathan A, Simmons GW, Christodoulides N, Floriano PN, Furmaga WB, Redding SW, Lu KH, Bast RC Jr, McDevitt JT.

Cancer Prev Res (Phila). 2012 May;5(5):706-16. doi: 10.1158/1940-6207.CAPR-11-0508. Epub 2012 Apr 9.

11.

Low-cost bioanalysis on paper-based and its hybrid microfluidic platforms.

Dou M, Sanjay ST, Benhabib M, Xu F, Li X.

Talanta. 2015 Dec 1;145:43-54. doi: 10.1016/j.talanta.2015.04.068. Epub 2015 May 6.

PMID:
26459442
12.

Correlation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C.

Nadeem A, Hussain MM, Aslam M.

J Coll Physicians Surg Pak. 2010 Oct;20(10):657-61. doi: 10.2010/JCPSP.657661.

PMID:
20943107
13.

[FibroMeters: a family of blood tests for liver fibrosis with high diagnostic performance and applicability in clinical practice].

Calès P, Boursier J, Oberti F, Gallois Y, Rousselet MC, Moal V, Macchi L, Chevailler A, Lunel F.

Pathol Biol (Paris). 2009 Sep;57(6):459-62. doi: 10.1016/j.patbio.2008.09.009. Epub 2008 Dec 2. French. No abstract available.

PMID:
19054629
14.

Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy.

Levine RA, Ranek L.

Gastroenterology. 1970 Mar;58(3):371-8. No abstract available.

PMID:
5437991
15.

Effects of clinical laboratory choice on study outcome: an interlaboratory evaluation of aminotransferase levels.

Green JL, Campagna E, Bogdan GM, Dart RC, Heard K.

Pharmacotherapy. 2008 Apr;28(4):453-7. doi: 10.1592/phco.28.4.453.

PMID:
18363529
16.

Effect of dilution on aminotransferase activity (AspAT and AIAT) in patients with viral hepatitis.

Rosnowska M.

Pol Med J. 1970;9(2):429-32. No abstract available.

PMID:
5422808
17.

Stability of AST and ALT assays in tris buffers.

Prasad R, Firkins K, Fiorello J.

Clin Chem. 1990 Feb;36(2):407-8. No abstract available.

PMID:
2091614
18.

Alteration in aminotransferase levels in rats after acute hepatic injury.

Mizrahi S, Dolberg L, Jacobsohn WZ.

Isr J Med Sci. 1987 Mar;23(3):188-92.

PMID:
3583700
19.

Paper-based microfluidic point-of-care diagnostic devices.

Yetisen AK, Akram MS, Lowe CR.

Lab Chip. 2013 Jun 21;13(12):2210-51. doi: 10.1039/c3lc50169h. Epub 2013 May 8. Review.

PMID:
23652632
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk